Fort, L.P. Medpace Holdings, Inc. Transaction History

Fort, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$130.2 - $168.03 $215,741 - $278,425	-1,657 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $159,978 - $246,885	-1,152 Reduced 41.01%	1,657 $271,000
Q4 2021 Feb 11, 2022	SELL	$182.74 - $227.9 $445,337 - $555,392	-2,437 Reduced 46.45%	2,809 $611,000
Q3 2021 Nov 12, 2021	SELL	$170.18 - $198.21 $231,104 - $269,169	-1,358 Reduced 20.56%	5,246 $993,000
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $147,992 - $181,281	-933 Reduced 12.38%	6,604 $1.17 Million
Q1 2021 May 14, 2021	BUY	$132.02 - $168.26 $204,895 - $261,139	1,552 Added 25.93%	7,537 $1.24 Million
Q4 2020 Feb 12, 2021	BUY	$109.38 - $149.19 $654,639 - $892,902	5,985 New	5,985 $833,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

Stay updated on Fort, L.P. with notifications on news.